Discrimination between patients with melancholic depression and healthy controls: Comparison between 24-h cortisol profiles, the DST and the Dex/CRH test

Psychoneuroendocrinology

Volumn 36, Issue 5, 2011, Pages 691-698

  Paslakis, Georgios ^a   Krumm, Bertram ^a   Gilles, Maria ^a   Schweiger, Ulrich ^c,d   Heuser, Isabella ^b,c   Richter, Inga ^a   Deuschle, Michael ^a,c  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^d UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Depression; Dexamethasone suppression test; Dexamethasone CRH test; HPA axis; Plasma cortisol

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; HYDROCORTISONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DEXAMETHASONE CORTICOTROPIN RELEASING HORMONE TEST; DEXAMETHASONE SUPPRESSION TEST; ENDOCRINE FUNCTION TEST; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTERMETHOD COMPARISON; MALE; MELANCHOLIA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS;

ADULT; AGED; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER; DEXAMETHASONE; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, ENDOCRINE; FEMALE; HEALTH; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; METABOLOME; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; TIME FACTORS;

EID: 79955521223     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2010.10.002     Document Type: Article

References (26)

1. Appelhof B.C., Huyser J., et al. Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression). Biol. Psychiatry 2006, 59(8):696-701.
2. Arana G.W. Dexamethasone suppression test in the diagnosis of depression. JAMA 1991, 265(17):2253-2254.
3. Aubry J.M., Gervasoni N., et al. The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients. J. Psychiatr. Res. 2007, 41(3-4):290-294.
4. Binder E.B., Künzel H.E., et al. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients. Psychoneuroendocrinology 2009, 34:99-109.
5. Bowers G., Cullinan W.E., et al. Region-specific regulation of glutamic acid decarboxylase (GAD) mRNA expression in central stress circuits. J. Neurosci. 1998, 18(15):5938-5947.
6. Carpenter L.L., Ross N.S., et al. Dex/CRH test cortisol response in outpatients with major depression and matched healthy controls. Psychoneuroendocrinology 2009, 34:1208-1213.
7. Cohen J. Statistical power analysis for the behavioral sciences 1988, Lawrence Erlbaum Associates, Inc., Publishers, Hillsdale, New Jersey 07642. 2nd ed.
8. Deuschle M., Schweiger U., et al. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test. Biol. Psychiatry 1998, 43(10):762-766.
9. Deuschle M., Schweiger U., et al. Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J. Clin. Endocrinol. Metab. 1997, 82:234-238.
10. Hatzinger M., Hemmeter U.M., et al. The combined DEX-CRH test in treatment course and long-term outcome of major depression. J. Psychiatr. Res. 2002, 36(5):287-297.
11. Heuser I., Yassouridis A., et al. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J. Psychiatr. Res. 1994, 28(4):341-356.
12. Holsboer F., Gerken A., et al. Mean 14:00-17:00h plasma cortisol concentration and its relationship to the 1-mg dexamethasone suppression response in depressives and controls. Acta Psychiatr. Scand. 1984, 69:383-390.
13. Holsboer F. Antidepressant drug discovery in the postgenomic era. World J. Biol. Psychiatry 2001, 2(4):165-177.
14. Ising M., Horstmann S., et al. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?. Biol. Psychiatry 2007, 62(1):47-54.
15. Ising M., Kunzel H.E., et al. The combined dexamethasone/CRH test as a potential surrogate marker in depression. Review. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29(6):1085-1093.
16. Kovacs K.J., Miklos I.H., et al. GABAergic mechanisms constraining the activity of the hypothalamo-pituitary-adrenocortical axis. Ann. N.Y. Acad. Sci. 2004, 1018:466-476.
17. Knorr U., Vinberg M., et al. Salivary cortisol in depressed patients versus control persons: a systematic review and meta-analysis. Psychoneuroendocrinology 2010, 35:1275-1286.
18. Kunugi H., Ida I., et al. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a multicenter study. Neuropsychopharmacology 2006, 31(1):212-220.
19. Modell S., Yassouridis A., et al. Corticosteroid receptor function is decreased in depressed patients. Neuroendocrinology 1997, 65(3):216-222.
20. Paslakis G., Heuser I., Schweiger U., Deuschle M. A single DEX/CRH test in male drug-free depressed patients is associated with the clinical response to treatment with fluoxetine. J. Psychiatr. Res. 2010, doi:10.1016/j.jpsychires.2010.04.010.
21. Raison C.L., Miller A.H. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am. J. Psychiatry 2003, 160(9):1554-1565.
22. Rush A.J., Giles D.E., et al. The dexamethasone suppression test in patients with mood disorders. J. Clin. Psychiatry 1996, 57(10):470-484.
23. Thompson L.M., Rubin R.T., et al. Neuroendocrine aspects of primary endogenous depression: XII. Receiver operating characteristic and kappa analysis of serum and urine cortisol measures in patients and matched controls. Psychoneuroendocrinology 1992, 17(5):507-515.
24. Watson S., Gallagher P., et al. Hypothalamic-pituitary-adrenal axis function in patients with chronic depression. Psychol. Med. 2002, 32(6):1021-1028.
25. Watson S., Gallagher P., et al. The dex/CRH test - is it better than the DST?. Psychoneuroendocrinology 2006, 31(7):889-894.
26. Zobel A., Nickel T., et al. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression: a prospective study. J. Psychiatr. Res. 2001, 35(2):83-94.